Co-Chief Editors

Anne S. De Groot, M.D.
Director, TB/HIV Research Lab, Brown Medical School

Deputy Editors

Frederick L. Altice, M.D.
Director, HIV in Prisons Program, Yale University AIDS Program

David P. Paar, M.D.
Director, AIDS Care and Clinical Research Program, University of Texas, Medical Branch

Senior Advisors

Karl Brown, M.D.
Rikers Island Jail

John H. Clark, M.D., M.P.H., F.S.C.P.
Los Angeles County Sheriff's Department

Theodore M. Hammett, Ph.D.
Abt Associates

Ned E. Heltzer, R.Ph., M.S.
Heltzer Associates

Ralf Jürgens
Canadian HIV/AIDS Law Legal Network

Joseph Paris, Ph.D., M.D.
CCHP Georgia Dept. of Corrections

Renee Ridzon, M.D.
Bill & Melinda Gates Foundation

Mary Sylla, M.D.
CorrectHELP: Corrections HIV Education Law Project

David Thomas, J.D., M.D.
Division of Correctional Medicine, NovaSoutheastern University College of Osteopathic Medicine

Louis C. Tripoli, M.D., F.A.C.F.E.
Correctional Medical Institute, Correctional Medical Services

Lester Wright, M.D.
New York State Dept. of Corrections

Associate Editors

Scott Allen, M.D.
Rhode Island Department of Corrections

Peter J. Piliero, M.D.
Associate Professor of Medicine, Consultant, NYS Department of Corrections, Albany Medical College

Dean Rieger, M.D.
Indiana Department of Corrections

Josiah Rich, M.D.
Brown University School of Medicine, The Miriam Hospital

Steven F. Scheibel, M.D.
Regional Medical Director, Prison Health Services, Inc.

David A. Wohl, M.D.
University of North Carolina

Michelle Gaseau
The Corrections Connection

Layout

Kimberly Backlund-Lewis
The Corrections Connection

Distribution

Screened Images Multimedia

Managing Editors

Elizabeth Herbert
HIV/Hepatitis Education Prison Project

Julia Noguchi
HIV/Hepatitis Education Prison Project

The editorial board and contributors to HEPP Report include national and regional correctional professionals, selected on the basis of their experience with HIV and hepatitis care in the correctional setting.

Faculty Disclosure

In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the faculty for this activity have been asked to complete Conflict of Interest Disclosure forms. Disclosures are listed at the end of articles. All of the individual medications discussed in this newsletter are approved for treatment of HIV and hepatitis unless otherwise indicated. For the treatment of HIV and hepatitis infection, many physicians opt to use combination antiretroviral therapy which is not addressed by the FDA.

HEPP Report is grateful for the support of the following companies through unrestricted educational grants:

• Major Support: Abbott Laboratories, Agouron Pharmaceuticals and Roche Pharmaceuticals

• Sustaining: Boehringer-Ingelheim Pharmaceuticals, Gilead Sciences Inc., GlaxoSmithKline, Merck & Co., and Schering-Plough.